Market Tracker

12/18 3:58pm ET

Nektar Therapeutics (NASDAQ:NKTR)

15.61
Real-Time Quote
 +0.405 / +2.66%
Today’s Change
10.10
Today|||52-Week Range
17.53
+37.53%
Year-to-Date

Today’s Trading

Previous close15.21
Today’s open15.40
Day’s range15.20 - 15.72
Volume647,935
Average volume (3 months)1,339,503
Market cap$2.0B
Dividend yield--
Data as of 3:43pm ET, 12/18/2014

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+69.13%
Earnings growth (next 5 years)+53.58%
Revenue growth (last year)+83.42%
P/E ratioNM
Price/Sales8.82
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DYAXDyax Corp+0.51+3.48%
ABCOAdvisory Board Co-2.31-4.49%
FGENFibroGen Inc+0.47+1.72%
INCRINC Research Holding...+0.51+2.14%
Data as of 3:58pm ET, 12/18/2014

Financials

Next reporting dateFebruary 25, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$148.9M
Annual profit (last year)-$162.0M
Net profit margin-108.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts